Form 4: Prestige Consumer Healthcare VP Sells Shares

Sentiment:

Insider Transaction Report


Jeffrey Zerillo, Senior VP Operations at Prestige Consumer Healthcare Inc., sold 1,000 shares of common stock for $60.00 per share in pre-planned transactions.

Summary

  • Jeffrey Zerillo, Senior VP Operations at Prestige Consumer Healthcare Inc. (PBH), disposed of a total of 1,000 shares of the company's common stock.
  • The sales occurred in two separate transactions: 719 shares on November 28, 2025, and 281 shares on December 1, 2025.
  • All shares were sold at a price of $60.00 per share.
  • These transactions were executed pursuant to a Rule 10b5-1(c) plan, indicating they were pre-scheduled.
  • Following these reported transactions, Mr. Zerillo's direct beneficial ownership stands at 42,048 shares of common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While insider selling can be perceived negatively, the fact that these transactions were executed under a pre-planned Rule 10b5-1 program mitigates some of the negative implications, suggesting a scheduled event rather than a reaction to new, undisclosed information. The amount sold is also not exceptionally large relative to the insider's remaining holdings.

Negatives

  • An insider, the Senior VP Operations, sold 1,000 shares of company common stock.
  • While pre-planned, insider selling can sometimes be interpreted by the market as a lack of confidence or a belief that the stock is fully valued.

Risks

  • Potential negative market perception due to insider selling, even if the transactions were pre-planned under a Rule 10b5-1 plan.
  • The sale could be interpreted by some investors as a signal that the insider believes the stock price may not appreciate significantly in the near term.

Future Outlook

NA

Industry Context

This Form 4 filing details an individual insider transaction and does not provide information directly related to broader industry trends or competitive landscape, beyond the general context of insider trading regulations for publicly traded companies.

Related Party Transactions

  • Jeffrey Zerillo, Senior VP Operations, sold 1,000 shares of Prestige Consumer Healthcare Inc. common stock, which is considered a related party transaction as it involves an insider.

Stakeholder Impact

  • Shareholders: May interpret the insider sale as a signal, potentially leading to minor negative sentiment or a re-evaluation of the stock's near-term prospects, though the 10b5-1 plan mitigates this concern.

Key Dates

DateDescription
August 7, 2018Date of the power of attorney granted to William P'Pool to sign on behalf of Jeffrey Zerillo.
November 28, 2025Transaction date for the sale of 719 shares of common stock by Jeffrey Zerillo.
December 1, 2025Transaction date for the sale of 281 shares of common stock by Jeffrey Zerillo.
December 2, 2025Date the Form 4 was signed by William P'Pool as attorney-in-fact for Jeffrey Zerillo.

Recommendation

hold

While the sale of shares by a Senior VP could be a minor negative signal, the transaction was executed under a pre-planned 10b5-1 program, which suggests it's a routine diversification or liquidity event rather than a reaction to new adverse information. The relatively small number of shares sold (1,000) compared to the remaining beneficial ownership (42,048 shares) does not warrant a strong sell recommendation. Investors should hold and monitor future insider activity and company performance.

Keywords

Prestige Consumer Healthcare, PBH, Jeffrey Zerillo, Insider Trading, Form 4, Stock Sale, Senior VP Operations, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.